Grip Strength: Which Tests to Order Alongside It

What Grip Strength Actually Measures

Handheld dynamometry quantifies maximal isometric force of the forearm flexors and hand intrinsic muscles. The test takes fewer than 90 seconds. A patient squeezes a calibrated Jamar or Smedley dynamometer three times per hand, and the clinician records the highest single value in kilograms.

Why It Predicts More Than Hand Function

Grip strength correlates with total-body skeletal muscle force at r = 0.73 to 0.82, making it a reliable proxy for systemic muscle capacity [1]. The Prospective Urban Rural Epidemiology (PURE) study, which enrolled 139,691 adults in 17 countries, found that each 5 kg decrease in grip strength was linked to a 17% increase in all-cause mortality (HR 1.17, 95% CI 1.11 to 1.24) and a 7% increase in myocardial infarction risk [2]. That magnitude rivals or exceeds the prognostic power of systolic blood pressure in the same cohort.

Reference Ranges by Sex and Age

The European Working Group on Sarcopenia in Older People (EWGSOP2) consensus, published in Age and Ageing in 2019, defines probable sarcopenia as grip strength <27 kg in men or <16 kg in women [3]. The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project uses slightly lower thresholds: <26 kg and <16 kg, respectively, adjusted by BMI [4]. Values between these thresholds and the 25th population percentile warrant monitoring; values above the median are considered normal.

Why Grip Strength Alone Is Not Enough

Low grip strength flags risk but does not explain cause. A 58-year-old man with a reading of 24 kg could have primary sarcopenia from disuse, secondary sarcopenia from untreated hypogonadism, weakness driven by hypothyroidism, or deconditioning after a prolonged illness. Without paired assessments, the clinician cannot triage treatment.

The EWGSOP2 Diagnostic Algorithm

The EWGSOP2 guideline explicitly requires a three-step process: (1) screen with grip strength or chair-stand, (2) confirm with a muscle-mass measurement, and (3) grade severity with a physical performance test [3]. Skipping step two produces a label of "probable sarcopenia" only. Confirmed sarcopenia demands a body-composition scan.

Clinical Consequences of Incomplete Workup

Prescribing resistance exercise for a patient whose weakness stems from severe vitamin D deficiency (25(OH)D <10 ng/mL) without correcting that deficiency first limits strength gains. Similarly, starting testosterone replacement in a man with low grip strength but normal total testosterone wastes resources and introduces unnecessary risk. The paired-test panel described below closes these gaps.

Body Composition: DEXA

Dual-energy X-ray absorptiometry remains the gold-standard clinic-accessible tool for measuring appendicular lean mass (ALM). The EWGSOP2 defines low muscle mass as ALM/height² <7.0 kg/m² in men and <5.5 kg/m² in women [3].

What DEXA Adds to Dynamometry

DEXA separates fat mass from lean mass at the regional level, so the clinician can see whether a patient with low grip strength also has objectively reduced muscle tissue or simply poor neuromuscular activation. It also captures visceral adipose tissue (VAT), which correlates independently with metabolic syndrome and may compound the cardiovascular risk already flagged by weak grip.

Bioelectrical Impedance as an Alternative

When DEXA is unavailable, bioelectrical impedance analysis (BIA) offers a portable estimate of skeletal muscle mass. The EWGSOP2 accepts BIA-derived values, though precision is lower in patients with fluid overload, obesity, or extremes of hydration [3]. If BIA is used, pair it with a multi-frequency device calibrated against DEXA reference equations for the population in question.

Gait Speed and Chair-Stand Time

Physical performance tests confirm severity once low grip strength and low muscle mass have been documented.

Gait Speed Protocol

The standard protocol times a patient walking 4 meters at their usual pace. A speed below 0.8 m/s indicates severe sarcopenia per EWGSOP2 criteria [3]. The InCHIANTI study (N=1,030 community-dwelling adults aged 65 and older) showed that gait speed <0.8 m/s predicted three-year mortality with an area under the curve of 0.73 [5].

Five-Repetition Chair Stand

The patient rises from a standard-height chair five times without using their arms. A time exceeding 15 seconds is abnormal. This test taxes the quadriceps and hip extensors more than grip does, adding lower-extremity context. The Short Physical Performance Battery (SPPB), which combines gait speed, chair stand, and balance, is an alternative composite measure endorsed by the National Institute on Aging [6].

Serum 25-Hydroxyvitamin D

Vitamin D status is the single most correctable endocrine driver of muscle weakness. The ENDO Society's 2024 guideline recommends maintaining 25(OH)D between 30 and 50 ng/mL for musculoskeletal health in adults over 50 [7].

Evidence Linking Vitamin D to Muscle Function

A meta-analysis of 30 RCTs (N=5,615) published in Osteoporosis International found that vitamin D supplementation improved grip strength by a standardized mean difference of 0.25 (95% CI 0.12 to 0.39) in adults with baseline levels below 30 ng/mL [8]. The effect disappeared in vitamin D-replete participants, reinforcing the value of testing before supplementing.

Ordering and Interpretation

Order 25(OH)D (not 1,25-dihydroxyvitamin D, which reflects renal conversion rather than stores). Levels <20 ng/mL are deficient; 20 to 29 ng/mL are insufficient. Repletion with cholecalciferol 50,000 IU weekly for 8 weeks followed by 2,000 IU daily maintenance is a common protocol. Recheck at 12 weeks.

Testosterone Panel (Men)

The Endocrine Society's 2018 guideline states: "We recommend measuring fasting morning total testosterone using a reliable assay in men with symptoms or signs suggestive of testosterone deficiency" [9]. Low grip strength in a male patient over 40 qualifies as such a sign.

What to Order

Request total testosterone, free testosterone (calculated or by equilibrium dialysis), sex hormone-binding globulin (SHBG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Total testosterone below 300 ng/dL on two morning draws confirms biochemical hypogonadism. SHBG helps interpret borderline results: a total testosterone of 310 ng/dL with SHBG of 65 nmol/L may correspond to a functionally low free testosterone.

Testosterone, Lean Mass, and Strength

The Testosterone Trials (TTrials, N=790 men aged 65 and older) demonstrated that one year of transdermal testosterone gel increased leg-press strength by 2.6 kg and stair-climbing power, though grip strength specifically improved only in participants with the lowest baseline values [10]. Dr. Peter Snyder, the study's principal investigator, noted: "The physical function benefits were modest and concentrated in the weakest men, which is precisely the group clinicians should identify with screening tools like dynamometry" [10].

Thyroid Function Panel

Hypothyroidism causes proximal myopathy, fatigue, and measurable grip-strength decline. A TSH above 10 mIU/L is associated with a 3 to 5 kg reduction in grip strength compared to euthyroid controls matched for age and sex, according to data from the Leiden 85-Plus Study [11].

Recommended Tests

Order TSH and free T4. If TSH is suppressed (<0.4 mIU/L) with symptoms of hyperthyroidism (tremor, tachycardia, unintentional weight loss), add free T3 and thyroid-stimulating immunoglobulin. Both hypo- and hyperthyroidism impair muscle function through different mechanisms: hypothyroidism slows myosin heavy-chain cycling, while hyperthyroidism accelerates proteolysis.

When to Recheck

If levothyroxine is initiated, repeat TSH and free T4 at 6 to 8 weeks and recheck grip strength at 12 weeks to gauge functional recovery.

Inflammatory and Nutritional Markers

High-Sensitivity C-Reactive Protein

Chronic low-grade inflammation accelerates muscle protein breakdown via the ubiquitin-proteasome pathway. The Health ABC Study (N=3,075, aged 70 to 79) found that participants in the highest CRP quartile (above 6.1 mg/L) lost grip strength at nearly twice the rate of those in the lowest quartile over three years [12]. An hsCRP above 3 mg/L alongside low grip strength should prompt investigation for occult inflammatory or autoimmune disease.

Serum Albumin

Albumin below 3.5 g/dL indicates protein-calorie malnutrition or systemic inflammation, both of which degrade muscle. It is inexpensive and available on any comprehensive metabolic panel. The combination of low grip strength and low albumin carries a particularly high perioperative risk in surgical candidates, as shown in a 2019 systematic review in The Lancet (N=68,753 across 22 studies) [13].

Metabolic Panel: HbA1c and Fasting Glucose

Type 2 diabetes accelerates sarcopenia through insulin resistance, mitochondrial dysfunction, and advanced glycation end-product accumulation in muscle fibers.

The Strength-Glucose Connection

A cross-sectional analysis from NHANES III (N=2,190 adults aged 60 and older) found that participants with HbA1c above 7.0% had grip strength values 1.8 kg lower in men and 1.2 kg lower in women compared to normoglycemic controls after adjustment for age, BMI, and physical activity [14]. The American Diabetes Association includes functional assessments in its 2024 Standards of Care for older adults with diabetes [15].

Practical Orders

Include HbA1c and fasting glucose. If HbA1c is 5.7% to 6.4% (prediabetes range), early intervention with metformin or lifestyle modification may preserve muscle function over time. Some emerging evidence suggests metformin itself may have a mild negative effect on muscle protein synthesis at high doses, so monitoring grip strength longitudinally in metformin-treated patients is reasonable.

Additional Paired Tests by Clinical Scenario

Not every patient with low grip strength needs every test. The table below matches clinical context to the most informative add-on orders.

| Clinical Scenario | Priority Paired Tests | |---|---| | Man over 50, fatigue, low libido | Total/free testosterone, LH, SHBG, DEXA | | Postmenopausal woman, fracture history | DEXA, 25(OH)D, calcium, PTH, bone turnover markers | | Obese patient with metabolic syndrome | HbA1c, fasting insulin, lipid panel, hsCRP, DEXA (for VAT) | | Chronic fatigue, weight gain | TSH, free T4, CBC, ferritin, 25(OH)D | | Recent hospitalization or surgery | Albumin, prealbumin, CRP, CBC, gait speed | | Suspected inflammatory myopathy | CK, aldolase, ESR, ANA, anti-Jo-1 antibodies |

How Often to Repeat Testing

The International Conference on Sarcopenia and Frailty Research recommends reassessing grip strength every 6 to 12 months in at-risk adults [16]. Dr. Alfonso Cruz-Jentoft, lead author of the EWGSOP2 consensus, has stated: "Serial dynamometry is the simplest way to track whether an intervention is working. A gain of 2 to 3 kg over six months is clinically meaningful" [3].

Tracking Trajectory Over Absolute Values

A single measurement tells less than a trend. A patient who moves from 22 kg to 26 kg over six months with testosterone optimization and structured resistance training is responding, even though 26 kg remains below the 27 kg EWGSOP2 cut-point. Conversely, a decline of more than 5% per year warrants urgent workup for new-onset disease or medication side effects (statins, corticosteroids, proton pump inhibitors).

For patients starting hormone replacement, resistance training, or nutritional repletion, repeat grip strength at the 12-week mark alongside the specific paired lab being corrected (e.g., 25(OH)D recheck at 12 weeks, testosterone recheck at 8 to 12 weeks).